These proteins include cancer antigen 125 (CA125) in ovarian cancer, alpha-fetoprotein (AFP) in liver cancer, carcinoembryonic antigen (CEA) in colon cancer, and prostate-specific antigen (PSA) in prostate cancer. This evidence concerns the gene MUC16 and ovarian cancer.